SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-18-000238
Filing Date
2018-08-06
Accepted
2018-08-06 12:50:25
Documents
61
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rgbp063018form10q.htm 10-Q 908326
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 164176
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 75327
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 8033
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 7934
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 4693
7 EXHIBIT 32.2 ex32_2.htm EX-32.2 4604
  Complete submission text file 0001607062-18-000238.txt   3973474

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE rgbp-20180630.xml EX-101.INS 690499
9 XBRL SCHEMA FILE rgbp-20180630.xsd EX-101.SCH 44258
10 XBRL CALCULATION FILE rgbp-20180630_cal.xml EX-101.CAL 39418
11 XBRL DEFINITION FILE rgbp-20180630_def.xml EX-101.DEF 136883
12 XBRL LABEL FILE rgbp-20180630_lab.xml EX-101.LAB 208474
13 XBRL PRESENTATION FILE rgbp-20180630_pre.xml EX-101.PRE 197146
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 18994162
SIC: 2834 Pharmaceutical Preparations